Innate Pharma is a global, clinical-stage biotechnology and immuno-oncology company specializing in the discovery and development of innovative therapeutic antibodies, antibody-drug conjugates, and multi-specific natural killer cell engagers. Operating as a publicly traded corporate entity listed on Euronext Paris and the U.S. Nasdaq exchange, the firm focuses its scientific expertise on harnessing the human immune system to target various hematological malignancies and solid tumor indications.